NP-101 Drug Development Plan
Novatek pipeline is focused on development of immunomodulatory drugs related to cancers and infectious diseases
Joint IP Project
BioSimilar Drug:
Biosimilars are developed based on information from testing the reference product and matching critical quality attributes (CQAs)
